Monday, December 06, 2021

NEWS

India takes measures against mucormycosis disease

India takes measures against mucormycosis disease

New Delhi, May 13 (Prensa Latina) India is taking measures to increase the availability of Amphotericin B to fight against mucormycosis, a health complication following the Covid-19 disease, it was reported in the capital.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Some states of the country are witnessing a surge in demand for the drug, which doctors are actively prescribing for the disease, All India Radio informed.

The supply situation is expected to improve with additional imports of the drug and growth of its domestic production, the source referred.

Mucormycosis is a fungal infection of the sinuses, brain or lungs.

It occurs in patients with weak immune systems and conditions such as Acquired Immunodeficiency Virus (HIV)-AIDS, burns, poorly controlled diabetes, leukemia and lymphoma, prolonged use of steroids, metabolic acidosis, malnutrition and the use of some medications.

Mucormycosis has a high mortality rate and the risk of dying depends on the area of the body affected and the patient’s general health.

rly/omr/ga/abm

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.